Ye Liu
Chief Executive Officer at OCUMENSION THERAPEUTICS
Net worth: 22 M $ as of 2024-03-30
Ye Liu active positions
Companies | Position | Start | End |
---|---|---|---|
OCUMENSION THERAPEUTICS | Director/Board Member | 2018-11-22 | - |
Chief Executive Officer | 2018-07-31 | - | |
EYEPOINT PHARMACEUTICALS, INC. | Director/Board Member | 2020-12-31 | - |
Career history of Ye Liu
Former positions of Ye Liu
Companies | Position | Start | End |
---|---|---|---|
Santen Pharmaceutical (China) Co. Ltd. | Chief Executive Officer | 2014-09-30 | 2018-06-30 |
Chairman | 2014-09-30 | 2018-06-30 | |
Eisai China, Inc.
Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China. | Chief Executive Officer | 2009-01-31 | 2014-08-31 |
Corporate Officer/Principal | - | - | |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The private company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Sales & Marketing | 2006-09-30 | 2009-01-31 |
Training of Ye Liu
Dalhousie University | Graduate Degree |
Zhongshan Hospital Fudan University | Undergraduate Degree |
Statistics
International
China | 6 |
United States | 2 |
Canada | 2 |
Operational
Chief Executive Officer | 3 |
Director/Board Member | 2 |
Chairman | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
OCUMENSION THERAPEUTICS | Health Technology |
Private companies | 3 |
---|---|
Santen Pharmaceutical (China) Co. Ltd. | |
Eisai China, Inc.
Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China. | Health Technology |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The private company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Health Technology |
- Stock Market
- Insiders
- Ye Liu
- Experience